Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DKF-MA102 in Advanced Prostate Cancer
NCT06490328Phase 3Completed
- Sponsor
- Dongkook Pharmaceutical
- Start
- May 2024
- Primary completion
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of Leugon in prostate cancer (PCa), sponsored by Dongkook Pharmaceutical. Started May 2024; status: completed.
02
Drugs
Leugon
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06490328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06490328.